[
  {
    "ts": "2025-10-17T18:41:18+00:00",
    "headline": "Inflation Data, Intel and Tesla Earnings: What to Watch Next Week",
    "summary": "The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Next Friday brings a (delayed) look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-17-2025/card/inflation-data-intel-and-tesla-earnings-what-to-watch-next-week-rR5HH1XuDronqdL1hknx?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "defff5a9-1d50-3d96-9427-96e4ff662b00",
      "content": {
        "id": "defff5a9-1d50-3d96-9427-96e4ff662b00",
        "contentType": "STORY",
        "title": "Inflation Data, Intel and Tesla Earnings: What to Watch Next Week",
        "description": "",
        "summary": "The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Next Friday brings a (delayed) look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.",
        "pubDate": "2025-10-17T18:41:18Z",
        "displayTime": "2025-10-17T18:41:18Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/defff5a9-1d50-3d96-9427-96e4ff662b00/inflation-data-intel-and.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/05766f3173ada94d07d55c12d565fe11",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/74Y7puEtMTJo02esBmIMTg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/05766f3173ada94d07d55c12d565fe11.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ng98BxS_YdX7FknFQwiRaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/05766f3173ada94d07d55c12d565fe11.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-17-2025/card/inflation-data-intel-and-tesla-earnings-what-to-watch-next-week-rR5HH1XuDronqdL1hknx?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INTC"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "PM"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "PG"
            },
            {
              "symbol": "GE"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "RTX"
            },
            {
              "symbol": "TXN"
            },
            {
              "symbol": "GM"
            },
            {
              "symbol": "COF"
            },
            {
              "symbol": "MAT"
            },
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "T"
            },
            {
              "symbol": "IBM"
            },
            {
              "symbol": "TMO"
            },
            {
              "symbol": "GEV"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "F"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T16:22:15+00:00",
    "headline": "Boston Scientific acquires Nalu Medical for $533m",
    "summary": "Nalu’s PNS system complements Boston’s existing neuromodulation portfolio, which includes its WaveWriter Alpha SCS system for chronic spinal pain.",
    "url": "https://www.medicaldevice-network.com/news/boston-scientific-acquires-nalu-medical-for-533m/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "d02157c8-f358-3b77-8446-454b1e9d67be",
      "content": {
        "id": "d02157c8-f358-3b77-8446-454b1e9d67be",
        "contentType": "STORY",
        "title": "Boston Scientific acquires Nalu Medical for $533m",
        "description": "",
        "summary": "Nalu’s PNS system complements Boston’s existing neuromodulation portfolio, which includes its WaveWriter Alpha SCS system for chronic spinal pain.",
        "pubDate": "2025-10-17T16:22:15Z",
        "displayTime": "2025-10-17T16:22:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/892820f2cf7177fa06d527a99be56c56",
          "originalWidth": 1440,
          "originalHeight": 960,
          "caption": "Nalu Medical's PNS bolsters Boston Scientific's existing SCS systems for addressing chronic pain. Image credit: JHVEPhoto via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eFhh4WYyTl_ycN2IsNbEsw--~B/aD05NjA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/892820f2cf7177fa06d527a99be56c56.cf.webp",
              "width": 1440,
              "height": 960,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qFZkW9D8WBT1qePpFoI9Cg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/892820f2cf7177fa06d527a99be56c56.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/boston-scientific-acquires-nalu-medical-for-533m/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-acquires-nalu-medical-162215716.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T13:15:04+00:00",
    "headline": "Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics",
    "summary": "Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.",
    "url": "https://finance.yahoo.com/news/unlocking-q3-potential-boston-scientific-131504551.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "67503b27-b8bb-366c-941b-8f8c844a2128",
      "content": {
        "id": "67503b27-b8bb-366c-941b-8f8c844a2128",
        "contentType": "STORY",
        "title": "Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics",
        "description": "",
        "summary": "Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.",
        "pubDate": "2025-10-17T13:15:04Z",
        "displayTime": "2025-10-17T13:15:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94",
          "originalWidth": 900,
          "originalHeight": 588,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5gRNxwBpnI6i3Dv1dI7wfg--~B/aD01ODg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94.cf.webp",
              "width": 900,
              "height": 588,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3D4iv84vYyo09.dnUK_wsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/unlocking-q3-potential-boston-scientific-131504551.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/unlocking-q3-potential-boston-scientific-131504551.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T13:09:00+00:00",
    "headline": "Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?",
    "summary": "Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.",
    "url": "https://finance.yahoo.com/news/intuitive-surgical-pre-q3-analysis-130900217.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f748193a-c3d9-341e-a148-c5a5236086cf",
      "content": {
        "id": "f748193a-c3d9-341e-a148-c5a5236086cf",
        "contentType": "STORY",
        "title": "Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?",
        "description": "",
        "summary": "Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.",
        "pubDate": "2025-10-17T13:09:00Z",
        "displayTime": "2025-10-17T13:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ffe56c6b40972cd987bbb0cf256ae119",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ly2eKWIt2DGVNvSZ_c1.OQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ffe56c6b40972cd987bbb0cf256ae119.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Jcy0r8Ec0Arq0Msc4P7F2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ffe56c6b40972cd987bbb0cf256ae119.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/intuitive-surgical-pre-q3-analysis-130900217.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/intuitive-surgical-pre-q3-analysis-130900217.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T11:00:31+00:00",
    "headline": "Boston Scientific to buy Nalu Medical for $533M",
    "summary": "Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.",
    "url": "https://www.medtechdive.com/news/Boston-Scientific-acquires-Nalu-Medical-neurostimulation/803116/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "e88609a9-6ea2-373a-860f-4bacd665912a",
      "content": {
        "id": "e88609a9-6ea2-373a-860f-4bacd665912a",
        "contentType": "STORY",
        "title": "Boston Scientific to buy Nalu Medical for $533M",
        "description": "",
        "summary": "Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.",
        "pubDate": "2025-10-17T11:00:31Z",
        "displayTime": "2025-10-17T11:00:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/6f2c921e458c0bdbec82a4e6b2e150ce",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Boston Scientific's headquarters is in Marlborough, Massachusetts.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SydpRG0OUlg3arn0g7lt2w--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/6f2c921e458c0bdbec82a4e6b2e150ce.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6kZkJqYDm1YnQIfTxYuyLg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/6f2c921e458c0bdbec82a4e6b2e150ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/Boston-Scientific-acquires-Nalu-Medical-neurostimulation/803116/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-buy-nalu-medical-110031375.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T11:00:00+00:00",
    "headline": "Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.",
    "summary": "Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic pain.",
    "url": "https://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-110000318.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "7f742e99-acb8-32b2-b4c6-ed285b95258e",
      "content": {
        "id": "7f742e99-acb8-32b2-b4c6-ed285b95258e",
        "contentType": "STORY",
        "title": "Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.",
        "description": "",
        "summary": "Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic pain.",
        "pubDate": "2025-10-17T11:00:00Z",
        "displayTime": "2025-10-17T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888",
          "originalWidth": 400,
          "originalHeight": 209,
          "caption": "Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bqyalFkM.p2vF1LWkaMoDA--~B/aD0yMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888.cf.webp",
              "width": 400,
              "height": 209,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Oi.RxhAOmrA0KHLwcormRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-110000318.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-110000318.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T14:28:39+00:00",
    "headline": "Boston Scientific boosts chronic pain therapy portfolio with Nalu deal",
    "summary": "By Christy Santhosh (Reuters) -Medical device maker Boston Scientific said on Friday it will buy the remaining equity in privately held Nalu Medical for about $533 million in cash, expanding its",
    "url": "https://ca.finance.yahoo.com/news/boston-scientific-boosts-chronic-pain-142839802.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "4ecbc376-8d25-3466-817d-836dd9bda7f4",
      "content": {
        "id": "4ecbc376-8d25-3466-817d-836dd9bda7f4",
        "contentType": "STORY",
        "title": "Boston Scientific boosts chronic pain therapy portfolio with Nalu deal",
        "description": "",
        "summary": "By Christy Santhosh (Reuters) -Medical device maker Boston Scientific said on Friday it will buy the remaining equity in privately held Nalu Medical for about $533 million in cash, expanding its",
        "pubDate": "2025-10-17T14:28:39Z",
        "displayTime": "2025-10-17T14:28:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/84398cd945871e6e4eec91cf22bc1c26",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "A general view of the logo of Boston Scientific, a medical device developing and manufacturing company, in Galway, Ireland, April 11, 2025. REUTERS/Clodagh Kilcoyne",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/X7ZHfYaW.MPwjNH1OZppNw--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/84398cd945871e6e4eec91cf22bc1c26.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vOSvXhX_UC1iGijiT0IxAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/84398cd945871e6e4eec91cf22bc1c26.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/boston-scientific-boosts-chronic-pain-142839802.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-boosts-chronic-pain-142839802.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]